<DOC>
	<DOCNO>NCT00119665</DOCNO>
	<brief_summary>The researcher propose Phase II randomize , double-blind , placebo-controlled trial 180 healthy postmenopausal woman experience least 5 hot flash per day 35 hot flash per week . Women randomize one three arm : 4.5 grams/day ( dry weight extract ) MF101 , 9.0 grams/day ( dry weight extract ) MF101 placebo 12 week .</brief_summary>
	<brief_title>Clinical Trial Assessing Toxicity Efficacy MF101 Hot Flashes</brief_title>
	<detailed_description />
	<mesh_term>Hot Flashes</mesh_term>
	<criteria>Women age 40 60 . Currently receive medical care health care provider . Selfreport 5 hot flash per day 35 hot flash per week . Postmenopausal define 12 month spontaneous amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 30mlU/ml 6 week postsurgical bilateral oophorectomy without hysterectomy hysterectomy FSH level &gt; 30 mlU/ml . Agree start new herbal dietary supplement change dose currently use herbal dietary supplement duration trial . Successful completion Hot Flash Diary , Daily Study Medication Diary Bleeding Diary , tolerate placebo , 80 % compliant runin . Must mammogram within last 9 month . Have access phone . Provide inform consent . Inability sign inform consent fill questionnaire . History breast , uterine ovarian cancer melanoma . Abnormal mammogram breast examination within last 9 month suggestive cancer . Abnormal Pap smear pelvic examination within last 9 month suggestive cancer . Doublewall endometrial thickness exceed 5 mm measure transvaginal ultrasound . Unexplained abnormal uterine bleeding within six month enrollment . Pregnancy lactate . Clinical evidence active ischemic cardiovascular disease history cardiovascular disease . History deep vein thrombosis pulmonary embolism require anticoagulation . Active liver gallbladder disease . Use medication , herbal dietary supplement know possibly effective treatment hot flash within three month enrollment oral transdermal drug , within 6 month enrollment implant injected drug . Use raloxifene tamoxifen within three month enrollment . Use another investigational agent within 3 month enrollment . History multiple severe food medicine allergy . Any medical psychiatric condition , investigator 's opinion , would preclude participant adhere protocol complete trial , include severe illness , plan move , substance abuse , significant problem , dementia .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Postmenopausal symptom</keyword>
	<keyword>Hot Flashes</keyword>
	<keyword>Postmenopausal Hot Flashes</keyword>
</DOC>